<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03619226</url>
  </required_header>
  <id_info>
    <org_study_id>CP284_1</org_study_id>
    <nct_id>NCT03619226</nct_id>
  </id_info>
  <brief_title>Evaluation of the Ability of Newly Developed Adhesives to Absorb Moisture</brief_title>
  <official_title>Evaluation of the Ability of Newly Developed Adhesives to Absorb Moisture</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Coloplast A/S</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Coloplast A/S</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of this evaluation is to investigate the ability of newly developed adhesive patches
      to absorb moisture.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">July 2, 2018</start_date>
  <completion_date type="Actual">July 4, 2018</completion_date>
  <primary_completion_date type="Actual">July 4, 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Resistance (Moisture in the adhesive)</measure>
    <time_frame>3 days</time_frame>
    <description>moisture in adhesive is measured using a measurement probe</description>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">6</enrollment>
  <condition>Stoma Ileostomy</condition>
  <arm_group>
    <arm_group_label>test patch</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>two adhesive patches are applied to the abdominal area</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>test patch</intervention_name>
    <description>the test patch consists of an adhesive patch</description>
    <arm_group_label>test patch</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Have given written informed consent

          2. Be at least 18 years of age and have full legal capacity

          3. Have intact skin on the area used in the evaluation

          4. Have an abdominal area accessible for application of test product (assessed by
             investigator)

          5. Negative pregnancy test for fertile women

          6. Signed document claiming use of safe contraceptives for fertile women

        Exclusion Criteria:

          1. Currently receiving or have within the past 2 month received radio- and/or
             chemo-therapy

          2. Currently receiving or have within the past month received topical steroid treatment
             in the peristomal skin area or systemic steroid (tablet/injection) treatment.

          3. Are pregnant or breastfeeding

          4. Having dermatological problems in the peristomal- or abdominal area (assessed by
             investigator)

          5. Participating in interventional clinical investigations or have previously
             participated in this evaluation. Exception: Participation in other Coloplast sponsored
             clinical investigations or evaluations is accepted under the circumstances that the
             subject has paused the activities in the investigation/evaluation and are otherwise
             complying with the inclusion and exclusion criteria of this (CP284) Evaluation
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Lene F Nielsen</last_name>
    <role>Principal Investigator</role>
    <affiliation>Head of the pre-clinical department</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Coloplast A/S</name>
      <address>
        <city>Humleb√¶k</city>
        <zip>3050</zip>
        <country>Denmark</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Denmark</country>
  </location_countries>
  <verification_date>August 2018</verification_date>
  <study_first_submitted>July 13, 2018</study_first_submitted>
  <study_first_submitted_qc>August 6, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">August 7, 2018</study_first_posted>
  <last_update_submitted>August 6, 2018</last_update_submitted>
  <last_update_submitted_qc>August 6, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">August 7, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

